With increasing use in cell biology and drug discovery, high content screening is gaining high steam in life sciences research. High content screening is increasingly used in research associated with cell shape, cell signaling as well as toxicology. It permits researchers to analyze multiple cell behavior and also allows them to measure cell response to chemical and environmental stimuli. These facets have significantly pushed the adoption of high content screening technology across various applications, to name a few, toxicity studies, compound profiling, target identification and validation and primary and secondary screening.
As per analysis done by Persistence Market Research, the global high content screening market is expected to witness a robust growth during 2017-2025. The global market for high content screening is also estimated to reach a value higher than US$ 2,100 Mn by end of the period of assessment (2025).
Increasing neurodegenerative diseases for instance, Alzheimer, cancer and Parkinson’s disease across the globe is expected to drive demand for advanced healthcare services. This has led international players across the globe to largely invest in research and development with a view to introduce innovative products to cater to the growing demand across the supply chain in the near future. Moreover, integration of analytics with data management is expected to drive the demand of high content screening. With a view to cater to growing demand from end users across the globe, instrument manufacturers and software developers are increasingly focusing on developing integrated solutions. Companies are developing automated solutions such as instruments with advanced visualization capabilities in line with enhanced software platform to sustain in the market that is being influenced by changing demographics at a global level. In addition, increased competitiveness is anticipated to compel players to launch highly developed and integrated high content screening instruments in the near future.
Other Factors Influencing the Demand for High Content Screening
Demand for high content screening is positively influenced by factors such as increasing need for outsourcing of drug discovery services, development of advanced imaging equipment, high demand for novel technologies, development of automated screening systems to analyze cell separation and cell stability and rising government support encouraging life sciences research activities. However, certain factors are expected to pose challenges to the growth of the global high content screening market. For instance, aspects such as high pricing of high content screening equipment has pushed the use of other image analysis instruments, for example, flow cytometers. Moreover, lack of budget for installation of high end high content screening equipment, especially in emerging economies has hampered the growth of global high content screening market. Skilled and efficient workforce is another key concern for companies operating in high content screening space.
High Content Screening Widely Used in Primary and Secondary Screening
With respect to applications, high content screening is expected to witness high adoption for primary and secondary screening. By end of the assessment period (2025), sale of high content screening equipment for primary and secondary screening is estimated to touch US$ 776 Mn. Moreover, use of high content screening in target identification and validation as well as in toxicity studies is expected to grow at a significant rate in the coming years.
High content screening is used across various industries such as pharmaceutical & healthcare, biotechnology, educational institutions, independent CRO, government organizations and others. Of these, pharmaceutical and healthcare industry is expected to largely contribute to the growth of the global market. By 2025 end, sale of high content screening equipment in this industry is estimated to surpass US$ 740 Mn. Also, as per this research, adoption of high content screening in biotechnology industry is projected to expand at a stellar pace in the coming years.
Key Companies in the Global High Content Screening Market
Major companies involved in global high content screening market include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher Corporation (Molecular Devices), Yokogawa Electric Corporation, Thorlabs, Inc., and Sysmex Corporation
For more insights on the global high content screening market, write in to Persistence Market Research analysts at email@example.com